Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

ClinicalTrials.gov ID: NCT05650333

Public ClinicalTrials.gov record NCT05650333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN INTERVENTIONAL PK, PD, PHASE 1, OPEN-LABEL STUDY TO INVESTIGATE PK AND PD OF MULTIPLE-DOSE RITLECITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA

Study identification

NCT ID
NCT05650333
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
15 participants

Conditions and interventions

Interventions

  • Ritlecitinib 20 mg Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2023
Primary completion
Aug 10, 2023
Completion
Aug 10, 2023
Last update posted
Oct 7, 2024

2023

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
California Dermatology & Clinical Research Institute Encinitas California 92024
Pediatric Skin Research,LLC Coral Gables Florida 33146
Nicklaus Children's Hospital Miami Florida 33155
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
University of New Mexico Health Sciences Center Albuquerque New Mexico 87102
UNMH Albuquerque New Mexico 87106
Vital Prospects Clinical Research Institute, PC Tulsa Oklahoma 74136
Northwest Dermatology Institute Portland Oregon 97210
Texas Dermatology and Laser Specialists San Antonio Texas 78218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05650333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05650333 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →